Hybrid Conferencee

International Conference on Hematology and Hemoglobinopathies (IC2H - 27)

12th - 13th April 2027 | Athens, Greece
Sample Abstract
Download
Conference Brochure
Sample Full Paper
Download
Expand the Academic Reach of Your Research - a Q1-ranked and Scopus-indexed journal publication opportunity

Journal consideration and publication are subject to editorial review, peer review and applicable journal policies.

Conference Notifications:

"Be sure to check this section regularly for all Research Plus International Conference updates. We’ll keep you informed about deadlines, event details, and more important notifications."

Call for Papers Extended:
"The deadline for full paper submissions has been extended for the Research Plus International Conference in Athens. Submit your research by today to participate in one of the top conferences."
Certificate of Presentation:
"Present your research and receive a Certificate of Presentation to recognise your valuable contribution to the conference."
Abstract Submissions Open:
"Abstract submissions for the Athens event are now open! Don’t miss the chance to present your research. Submit now."
Networking with Global Experts:
"Engage with researchers and professionals from around the world at the Athens conference. Build collaborations and gain insights from leading experts."
Keynote Speaker Sessions:
"Don’t miss our Keynote Sessions in Athens, featuring global leaders and innovators sharing their knowledge."
Best Paper & Best Paper Presentation Award:
"Submit your paper and stand a chance to win the Best Paper Presentation Award. The winner will be recognized at the conference in Athens."
SDG-Inspired Conference Focus:
"Our conference will highlight research that addresses global sustainability, inclusive education, and solutions for environmental challenges."

Conference Session Tracks

SDG Wheel

Aligned with

UN Sustainable Development Goals

This conference contributes to global sustainability by aligning its research discussions and academic sessions with key United Nations Sustainable Development Goals. It fosters knowledge exchange, innovation, and collaborative engagement.

SDG 3
SDG 3 Good Health and Well-being
SDG 4
SDG 4 Quality Education
SDG 9
SDG 9 Industry, Innovation and Infrastructure
Track 01

Advancements in Molecular Diagnostics for Hemoglobinopathies

This track focuses on the latest innovations in molecular diagnostic techniques for the identification of hemoglobinopathies. Emphasis will be placed on the integration of genomic technologies and their impact on patient outcomes.

Track 02

Patient-Centered Approaches in Hematology Care

This session will explore strategies for enhancing patient care in hematology, including shared decision-making and personalized treatment plans. Discussions will highlight the importance of patient engagement and education in managing hematological disorders.

Track 03

Transfusion Therapy: Current Practices and Future Directions

This track will examine contemporary practices in transfusion therapy, including indications, safety protocols, and emerging technologies. Participants will discuss the challenges and advancements in ensuring optimal transfusion outcomes for patients.

Track 04

Clinical Research Innovations in Hematology

This session will showcase groundbreaking clinical research studies that are shaping the future of hematology. Presentations will cover novel therapeutic approaches and their implications for clinical practice.

Track 05

Laboratory Techniques in Hematological Diagnostics

This track will delve into the latest laboratory techniques employed in the diagnosis of hematological disorders. Participants will gain insights into the role of automation and new technologies in enhancing diagnostic accuracy.

Track 06

Biomarker Discovery in Hematology: Implications for Therapy

This session will focus on the identification and validation of biomarkers in hematological diseases, exploring their potential role in guiding therapy. The discussions will highlight the translational aspects of biomarker research.

Track 07

Translational Research in Hemoglobinopathies

This track will address the bridge between basic research and clinical application in the context of hemoglobinopathies. Emphasis will be placed on how translational research can inform treatment strategies and improve patient outcomes.

Track 08

Understanding Disease Mechanisms in Hematology

This session will investigate the underlying mechanisms of various hematological disorders, including genetic and environmental factors. Participants will discuss how these insights can inform therapeutic approaches.

Track 09

Emerging Therapies for Hemoglobinopathies

This track will highlight novel therapeutic agents and strategies being developed for the treatment of hemoglobinopathies. Discussions will include clinical trial results and the potential for new treatment paradigms.

Track 10

Ethical Considerations in Hematology Research

This session will explore the ethical challenges associated with conducting research in hematology, particularly in vulnerable populations. Participants will engage in discussions about informed consent, data privacy, and equitable access to therapies.

Track 11

Global Perspectives on Hematology and Hemoglobinopathies

This track will provide a platform for discussing global health challenges related to hematology and hemoglobinopathies. Participants will share insights on disparities in care and strategies for improving access to treatment worldwide.